Company: CSCIF
Filing Date: 2025-04-09
Form Type: 20-F
Source: 0001641172-25-003456
Chunk: 99

Company: COSCIENS Biopharma Inc.
Filing Date: 2025-04-09
Form: 20-F
Item: Item 6
Chunk 99
---
 of equity-based awards based on the contribution of the officers and their responsibilities. The
Board adopted a policy regarding stock option grants in December 2014, which provides that each Named Executive Officer is eligible to
receive options to acquire our Common Shares having a value, based on the Black-Scholes option pricing model, equal to a specified multiple
of his or her salary. The specified multiple for the President and Chief Executive Officer is 1.5. The specified multiple for each other
Named Executive Officer is 0.75. To encourage retention and focus management on developing and successfully implementing our continuing
growth strategy, stock options vest over a period of three years, with the first third vesting on the first anniversary of the date of
grant. Since the adoption of the Long-Term Incentive Plan in 2018, we have broadened the types of equity-based awards which we may issue
beyond stock options (to include, among other types, restricted stock units (“ RSUs”), DSUs and others).

Other Forms of Compensation. Our executive
employee benefits program also includes life, medical, dental and disability insurance to the same extent and in the same manner as all
other employees as either enrollment in the payroll system benefits program or by additional percentage compensation to self-enroll in
private insurance policies. These benefits and perquisites are designed to be competitive overall with equivalent positions in comparable
North American organizations in the life sciences industry. We also contribute to our North American employees’ retirement plans
up to an annual maximum amount of $19,500 for employees in the United States and Canada. The contribution amounts for our United States
and Canadian employees are subject to limitations imposed by the United States Internal Revenue Service and the Canadian Revenue Agency
respectively, on contributions to our most highly compensated employees. Employees based in Frankfurt; Germany also benefit from certain
employer contributions into the employees’ pension funds. Our executive officers, including the Named Executive Officers, are eligible
to participate in such employer-contribution plans to the same extent and in the same manner as all other employees.

Positioning

The NGCC is authorized to engage its own independent
consultant to advise it with respect to executive compensation matters. While the NGCC may rely on external information and advice, all
of the decisions with respect to executive compensation are made by the Board upon the recommendation of the NGCC and may reflect factors
and considerations other than, or that may differ from, the information and recommendations provided by any external compensation consultants
that may be retained